1-2 hour modules

Module 2 of 2: This two-part activity provides education on the various long-acting buprenorphine (LAIB) formulations available in Australia, followed by a practical exercise where the learner goes through the steps of assessing whether a patient is suitable for LAIB treatment, and discusses with them how treatment may help them achieve their goals.

Behavioural and psychological symptoms of dementia (BPSD) can lead to quality of life impacts in not only the individual with dementia, but also others around them. This module explores the assessment of BPSD using the ABC (antecedent, behaviour, consequence) model, and discusses the management of BPSD using pharmacological and non-pharmacological methods as well as the management of comorbid conditions associated with dementia.

Module 2 of a 2-part series: Providing care for people with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) requires a patient-centred approach with a focus on quality of life and incorporating the multidisciplinary team. This second module on ME/CFS provides detail on making a differential diagnosis, the non-core symptoms of ME/CFS, management in specific populations, and the development of a patient-centred treatment plan.

This module looks at the common causes of under-diagnosis and misdiagnosis of hereditary haemochromatosis in Australia. Participants will learn how to determine when hereditary haemochromatosis should be part of their differential diagnosis. The module also covers iron study test results and how to explain these results to patients.

This module provides an overview of hereditary haemochromatosis and the symptoms of iron overload. Participants will gain an understanding of how to interpret iron study results, and how to determine when genetic testing is warranted. The module also covers how to access the therapeutic venesection service offered by the Australian Red Cross Blood Service.

In this module, participants will learn about appropriate induction and maintenance venesection schedules for patients with hereditary haemochromatosis, as well as circumstances that warrant referral to a specialist. Participants will also learn how to access the Australian Red Cross Blood Service (ARCBS) High Ferritin app, and how to use it to screen patients for their eligibility to access therapeutic venesection. The module also looks at how to access local alternatives to the ARCBS therapeutic venesection service.